Module 4 Flashcards

1
Q

What are the causes of a prolonged thrombin clotting time?

A
Heparin
Dabigatran
Dysfibrinogenaemia
Fibrin degradation products (DIC)
Liver disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are some acquired causes of thrombocytopenia?

A

Immune: ITP, SLE, malignancy associated antibodies
Drug induced: quinines, sulphurs, heparins
Viruses: EBV/HIV
Post-transfusion alloimmunity
TTP
DIC
Sequestration in splenomegaly
Decreased production eg: bone marrow failure, aplastic anaemia, alcohol toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the pathophysiology of TTP?

A

Congenital or acquired deficiency of ADAMTS13 (vWF cleaving enzyme)
Platelets aggregate, activate and self-consume

Fragemetary haemolysis and microvascular thrombosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are some acquired causes of platelet DYSFUNCTION?

A
  • myelodysplasia: adequate number but they’re dysfunctional
  • myeloproliferative: over-production
  • uraemia
  • drugs
  • diet: garlic, ginko, ginger
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How is vit K metabolised in the gut?
What is its role in coagulation?
What does warfarin do to change this?

A
  • Dietary Vit K is protein bound and released by pancreatic enzymes
  • Bile salts solubilize, incorporated into chylomicrons and transported to liver
  • Assists in carboxylation of II, VII, IX and X which assists in localisation to phospholipid
  • Warfarin blocks reduction of Vit K epoxide back to vit K, preventing it from γ carboxylation of coagulation factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are some causes of reduced clotting factors?

A

IMPAIRED PRODUCTION

  • liver disease
  • vit K deficiency

INCREASED DESTRUCTION

  • DIC
  • MTF
  • inhibitors

DYSFUNCTION
- anticoagulant meds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Differentiate between causes of palpable and non-palpable purpurae

A

Palpable purpura: fibrin activation within subcutaneous tissue
Vasculitis
Allergic

Non-palpable: red cell leakage into tissues due to reduced integrity of connective tissue
Small bruises
Senile

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are some of the key effects of sepsis on coagulation?

A
○ Increased leucocyte adhesion
○ Shift to procoagulant state
○ Vasodilation
○ Loss of barrier function
○ Microthrombi due to plugs of WBC and RBC

TF exposure, fibrin deposition and impaired activated protein C can produce DIC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the role of PAR1 and its link between coagulation and inflammation?

A

Protease-activated receptors (PAR1)

  • PAR1 cytoprotective when stimulated by activated protein-C or low-dose thrombin
  • With High dose thrombin, disrupts endothelial cell barrier function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the pathophysiology of acute/decompensated DIC

A
  1. Blood exposed to acute increased tissue factor or procoagulants
  2. Rapid consumption of coagulation factors
  3. FDPs disrupt normal fibrin polymerisation, clot formation and platelet aggregation
  4. Severe bleeding diathesis –> prolonged clotting times
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the pathophysiology of chronic/compensated DIC

A
  1. Continuous exposure to tissue factor/procoagulant
  2. Coag factors/platelets consumed but compensate with production
  3. Liver clears FDPs
  4. Normal clotting times, mild thrombocytopenia or normal
  5. Thrombosis > bleeding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the diagnostic criteria for DIC?

A

Plt: <100 1 pt, <50 2 pts
PT: 3-6 1 pt, >6 2 pt
Fibrinogen: <1 1 pt
d-dimer: moderate increase, 1 pt, strong increase 2 pt

<5 non-overt DIC, repeat testing in 1-2 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the indications for treatment in DIC?

A
  • Active bleeding
  • Require invasive procedures
  • High risk for bleeding complications
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the management of DIC?

A

TREAT UNDERLYING CAUSE

  • transfuse to plt >50
  • supplement FFP to correct PT/APTT
  • cryp + FFP to fibrinogen >1
  • avoid prothrombinex
  • LMWH prophylaxis
  • if clots, therapeutic heparin/LMWH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the PRO-haemostatic changes in chronic liver disease?

A

PRIMARY

  • low ADAMTS13
  • elevated vWF

SECONDARY

  • Low protein C, protein S, antithrombin, heparin cofactor II
  • elevated fVIII

FIBRINOLYSIS
- low plasminogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the ANTI-haemostatic changes in chronic liver disease?

A

PRIMARY

  • thrombocytopenia (splenic sequestration)and low function
  • decreased TPO (bone marrow suppression)
  • increased NO and prostacyclin

SECONDARY

  • low thrombin, fVII, V, IX, X, XI
  • vit K deficiency
  • dysfibrinogenaemia

FIBRIOLYSIS

  • low α-2 antiplasmin, XIII, TAFI
  • elevated tPA
17
Q

Management strategies for acute bleeding in chronic liver disease?

A
  • adjuncts: vasoconstrictors and endoscopy
  • plt >50
  • Hb 70-80
  • FFP to fibrinogen >1
  • prothrombinex to minimise volume
18
Q

What are some of the mechanisms of snake venom-induced consumptive coagulopathy?

A
  1. Thrombin-like enzymes: consume fibrinogen
  2. Prothrombin activators
  3. FX and FV activators
    - Group C: cleave prothrombin in 2 places resulting in activation without need for other clotting factors (eastern brown, coastal taipan)
    - look like Xa, require Va to convert pro-thrombin to thrombin (tiger snake)
19
Q

What are some indications for antivenom treatment?

A
  • Nausea/vomiting
  • Abdo pain
  • Diarrhoea
  • Diaphoresis
  • Headache
  • Leukocytosis
  • aPTT change
  • CK >1000
20
Q

Which antivenoms do you give for which snake bites?

A
  • Monovalent brown + tiger for brown, tiger or RBBS (most of Australia)
  • Polyvalent - taipan, death adder and mulga (FNW and snake handlers)
21
Q

What are the laboratory indications of venom-induced consumptive coagulopathy?

A
  • APTT prolonged
  • INR >3 (severe) INR <3 (partial)
  • Fibrinogen low/undetectable
  • Very high D-Dimer
22
Q

What is the mechanism of acquired vonWillebrand syndrome with ECMO?

A
  • High shear stress on vWF causing loss of HMW multimers

- Qualitative defect in vWF (type 2 vWD)

23
Q

What is the definition of primary ITP? What is the pathophysiology?

A

Isolated platelet <100 with no apparent non-immune cause

Anti GP antibodies
Platelet apoptosis due to T cll mediated cytolysis
Mesenchymal stem cells that usually act as chaparones are fewer
Deficient regulatory T and B cells

24
Q

What are the treatment options for ITP?

A
  1. Treat potential causes
  2. TXA
  3. Steroids
  4. IVIg
  5. Platelet transfusions

Second line

  • rituximab
  • splenectomy
  • MMF/ azothioprine etc.

Third line

  • TOP receptor agonists
  • chronic IVIG infusions
  • combination immunosuppression